02/20/2026
Most people still hesitate when they hear the word psilocybin. We get it.
Psychedelic-assisted therapy isn't for everyone. Knowing who it's truly for, and who it isn't, matters just as much as the science itself.
Last week, we explored the renaissance of psilocybin and how respected research institutions and clinicians are studying its therapeutic use in structured, supervised settings.
The conversation is now expanding beyond mental health into neuroplasticity, long-term brain health, and healthy aging.
Missed it? You can still catch up on The Psilocybin Issue here: https://na2.hubs.ly/H03PQk00
This Saturday, Professor Robin Carhart-Harris, Eudēmonia Summit expert and a leading voice in psychedelic-assisted therapy, takes on your questions about psilocybin.
In our Q&A issue, Dr. Carhart-Harris answers:
→ How do I know if I (or a loved one) is
a good candidate for psilocybin therapy?
→ When evaluating treatment providers and clinics, what should I look for?
→ What excites you most about the
next 5–10 years of psychedelic medicine?
Want to know more?
Hit the link to subscribe: https://na2.hubs.ly/H03PMD70